Literature DB >> 7847284

The intestinal response to critical illness.

J S Thompson1.   

Abstract

Critical illness is characterized by the presence of several factors that can cause marked alterations in the structure and function of multiple organ systems (1-2). These factors include injury, ischemia, sepsis, and starvation (Fig. 1). It is common for more than one of these problems to be present in the individual patient. Our current understanding of the effect of these various factors on intestinal structure and function has increased markedly during the past decade (3). Furthermore, the patterns of intestinal dysfunction that occur in response to these conditions have also been better characterized. Although malabsorption and motility disorders have long been recognized as clinical problems, more recently loss of intestinal barrier function and immune dysfunction have gained attention. This improved understanding of the response of the intestine to critical illness may lead to prevention of intestinal failure or permit more specific therapy when it occurs. The goals of this manuscript are to describe the response of the small intestine to critical illness and to identify potential therapeutic strategies for preventing and treating intestinal failure in this setting.

Entities:  

Mesh:

Year:  1995        PMID: 7847284

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Administration of bacterial lipopolysaccharide to rats induces heme oxygenase-1 and formation of antioxidant bilirubin in the intestinal mucosa.

Authors:  K Otani; S Shimizu; K Chijiiwa; T Morisaki; T Yamaguchi; K Yamaguchi; S Kuroki; M Tanaka
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

Review 2.  Bench-to-bedside review: the gut as an endocrine organ in the critically ill.

Authors:  Adam Deane; Marianne J Chapman; Robert J L Fraser; Michael Horowitz
Journal:  Crit Care       Date:  2010-09-24       Impact factor: 9.097

3.  Does coronary artery bypass surgery affect metoprolol bioavailability.

Authors:  Antti Valtola; Hannu Kokki; Merja Gergov; Ilkka Ojanperä; Veli-Pekka Ranta; Tapio Hakala
Journal:  Eur J Clin Pharmacol       Date:  2007-02-28       Impact factor: 2.953

4.  Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study.

Authors:  Denise R Silva; Diego M Menegotto; Luis F Schulz; Marcelo B Gazzana; Paulo Tr Dalcin
Journal:  BMC Infect Dis       Date:  2010-03-07       Impact factor: 3.090

5.  Interrupting drug therapy in the perioperative period.

Authors:  David W Noble; John Webster
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Effect of prolonged hyperdynamic endotoxemia on jejunal motility in fasted and enterally fed pigs.

Authors:  Maaike J Bruins; Yvette C Luiking; Peter B Soeters; Louis M A Akkermans; Nicolaas E P Deutz
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

Review 7.  Pulmonary tuberculosis in intensive care setting, with a focus on the use of severity scores, a multinational collaborative systematic review.

Authors:  J Galvin; S Tiberi; O Akkerman; H A M Kerstjens; H Kunst; X Kurhasani; N Ambrosino; G B Migliori
Journal:  Pulmonology       Date:  2022-02-26

8.  Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial).

Authors:  Peter J D Andrews; Alison Avenell; David W Noble; Marion K Campbell; Claire G Battison; Bernard L Croal; William G Simpson; John Norrie; Luke D Vale; Jonathon Cook; Robyn de Verteuil; Anne C Milne
Journal:  Trials       Date:  2007-09-20       Impact factor: 2.279

Review 9.  Clinical review: tuberculosis on the intensive care unit.

Authors:  Guy Hagan; Nazim Nathani
Journal:  Crit Care       Date:  2013-09-27       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.